These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 8400267)

  • 41. Treatment of newly diagnosed and relapsed acute promyelocytic leukemia with intravenous liposomal all-trans retinoic acid.
    Douer D; Estey E; Santillana S; Bennett JM; Lopez-Bernstein G; Boehm K; Williams T
    Blood; 2001 Jan; 97(1):73-80. PubMed ID: 11133744
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Common defects of different retinoic acid resistant promyelocytic leukemia cells are persistent telomerase activity and nuclear body disorganization.
    Nason-Burchenal K; Maerz W; Albanell J; Allopenna J; Martin P; Moore MA; Dmitrovsky E
    Differentiation; 1997 Aug; 61(5):321-31. PubMed ID: 9342843
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid).
    Warrell RP; Frankel SR; Miller WH; Scheinberg DA; Itri LM; Hittelman WN; Vyas R; Andreeff M; Tafuri A; Jakubowski A
    N Engl J Med; 1991 May; 324(20):1385-93. PubMed ID: 1850498
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Treatment of relapsing acute promyelocytic leukemia by all-trans retinoic acid therapy followed by timed sequential chemotherapy and stem cell transplantation. APL Study Group. Acute promyelocytic leukemia.
    Thomas X; Dombret H; Cordonnier C; Pigneux A; Gardin C; Guerci A; Vekhoff A; Sadoun A; Stamatoullas A; Fegueux N; Maloisel F; Cahn JY; Reman O; Gratecos N; Berthou C; Huguet F; Kotoucek P; Travade P; Buzyn A; de Revel T; Vilque JP; Naccache P; Chomienne C; Degos L; Fenaux P
    Leukemia; 2000 Jun; 14(6):1006-13. PubMed ID: 10865965
    [TBL] [Abstract][Full Text] [Related]  

  • 45. All-trans retinoic acid and hematopoietic growth factors regulating the growth and differentiation of blast progenitors in acute promyelocytic leukemia.
    Miyauchi J
    Leuk Lymphoma; 1999 Apr; 33(3-4):267-80. PubMed ID: 10221506
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Treatment of acute promyelocytic leukemia by all trans retinoic acid].
    Castaigne S; Degos L
    C R Seances Soc Biol Fil; 1995; 189(4):515-20. PubMed ID: 8564565
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Differentiation of extramedullary acute promyelocytic leukemia by all-trans-retinoic acid.
    Lederman CA; Weisberger J; Seiter K; Feldman EJ
    Leuk Lymphoma; 1995 Jun; 18(1-2):189-93. PubMed ID: 8580825
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Tamibarotene in patients with acute promyelocytic leukaemia relapsing after treatment with all-trans retinoic acid and arsenic trioxide.
    Sanford D; Lo-Coco F; Sanz MA; Di Bona E; Coutre S; Altman JK; Wetzler M; Allen SL; Ravandi F; Kantarjian H; Cortes JE
    Br J Haematol; 2015 Nov; 171(4):471-7. PubMed ID: 26205361
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Management of acute promyelocytic leukemia relapse in the ATRA era.
    Castagnola C; Lunghi M; Corso A; Tajana M; Zappasodi P; Dabusti M; Lazzarino M; Bernasconi C
    Haematologica; 1998 Aug; 83(8):714-7. PubMed ID: 9793255
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Expression of the Zn finger gene, EVI-1, in acute promyelocytic leukemia.
    Xi ZF; Russell M; Woodward S; Thompson F; Wagner L; Taetle R
    Leukemia; 1997 Feb; 11(2):212-20. PubMed ID: 9009083
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Designed ATRA analogue active against ATRA-resistant acute promyelocytic leukemia cells having a single nucleotide substitution in their retinoic acid receptor.
    Komura N; Ikeda Y; Masuda N; Umezawa Y; Ito K; Kizaki M; Umezawa K
    Leuk Res; 2007 Mar; 31(3):301-13. PubMed ID: 16968653
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effectiveness and pharmacokinetics of low-dose all-trans retinoic acid (25 mg/m2) in acute promyelocytic leukemia.
    Castaigne S; Lefebvre P; Chomienne C; Suc E; Rigal-Huguet F; Gardin C; Delmer A; Archimbaud E; Tilly H; Janvier M
    Blood; 1993 Dec; 82(12):3560-3. PubMed ID: 8260694
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Increased sensitivity to a vitamin D3 analog in HL-60 myeloid leukemic cells resistant to all-trans retinoic acid.
    Doré BT; Uskokovic MR; Momparler RL
    Leukemia; 1994 Dec; 8(12):2179-82. PubMed ID: 7528858
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Treatment of acute promyelocytic leukaemia in first relapse with all-trans retinoic acid.
    Wong K; Lim HL; Teo CP; Tan YO; Kueh YK
    Ann Acad Med Singap; 1995 Jan; 24(1):177-9. PubMed ID: 7605089
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Differentiation therapy of acute promyelocytic leukemia with all-trans retinoic acid].
    Ohno R
    Gan To Kagaku Ryoho; 1993 Feb; 20(2):189-93. PubMed ID: 8434955
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pharmacogenomic analysis of acute promyelocytic leukemia cells highlights CYP26 cytochrome metabolism in differential all-trans retinoic acid sensitivity.
    Quere R; Baudet A; Cassinat B; Bertrand G; Marti J; Manchon L; Piquemal D; Chomienne C; Commes T
    Blood; 2007 May; 109(10):4450-60. PubMed ID: 17218384
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Retinoic acid in the treatment of acute promyelocytic leukemia: inefficacy of the 13-cis isomer and induction of complete remission by the all-trans isomer complicated by thromboembolic events.
    Runde V; Aul C; Südhoff T; Heyll A; Schneider W
    Ann Hematol; 1992 Jun; 64(6):270-2. PubMed ID: 1637880
    [TBL] [Abstract][Full Text] [Related]  

  • 58. In vitro all-trans retinoic acid sensitivity of acute promyelocytic leukemia blasts: a novel indicator of poor patient outcome.
    Cassinat B; Chevret S; Zassadowski F; Balitrand N; Guillemot I; Menot ML; Degos L; Fenaux P; Chomienne C;
    Blood; 2001 Nov; 98(9):2862-4. PubMed ID: 11675363
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Transcription therapy for acute promyelocytic leukaemia.
    Douer D
    Expert Opin Investig Drugs; 2000 Feb; 9(2):329-46. PubMed ID: 11060680
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hematopoietic growth factor expression and ATRA sensitivity in acute promyelocytic blast cells.
    Dubois C; Schlageter MH; de Gentile A; Guidez F; Balitrand N; Toubert ME; Krawice I; Fenaux P; Castaigne S; Najean Y
    Blood; 1994 Jun; 83(11):3264-70. PubMed ID: 8193361
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.